Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Expert Review of Vaccines|October 9, 2013
Repositioning therapeutic cancer vaccines in the dawning era of potent immune interventionsAdrian Bot, Francesco Marincola, Kent A Smith
DNA and Cell Biology|July 3, 2004
Molecular and cellular control of T1/T2 immunity at the interface between antimicrobial defense and immune pathologyAdrian Bot, Kent A Smith, Matthias von Herrath
Journal of Translational Medicine|December 15, 2010
Programmed cell death-1 (PD-1) at the heart of heterologous prime-boost vaccines and regulation of CD8+ T cell immunityAdrian Bot, Zhiyong Qiu, Raymond Wong, et al.
Journal of Virology|June 7, 2002
Targeting and hematopoietic suppression of human CD34+ cells by measles virusMarianne Manchester, Kent A Smith, Danelle S Eto, et al.
European Journal of Immunology|May 24, 2005
Improving the therapeutic index of CpG oligodeoxynucleotides by intralymphatic administrationBarbara R von Beust, Pål Johansen, Kent A Smith, et al.
Blood|June 24, 2004
The role of angiopoietins in the development of endothelial cells from cord blood CD34+ progenitorsPatrick Hildbrand, Vincenzo Cirulli, Robyn C Prinsen, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 2005
Inhibition of tumor growth, angiogenesis, and tumor cell proliferation by a small molecule inhibitor of c-Jun N-terminal kinaseBruce W Ennis, Kimberly E Fultz, Kent A Smith, et al.
Immunology Letters|September 16, 2009
TLR-9 signaling and TCR stimulation co-regulate CD8(+) T cell-associated PD-1 expressionRaymond M Wong, Kent A Smith, Victor L Tam, et al.
Vaccine|May 12, 2009
Enhancing DNA vaccination by sequential injection of lymph nodes with plasmid vectors and peptidesKent A Smith, Victor L Tam, Raymond M Wong, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 26, 2008
Antigen kinetics determines immune reactivityPål Johansen, Tazio Storni, Lorna Rettig, et al.
Pageof 3